[1] LI C G,BREBI P,L??EZ J,et al. Genotyping of human papillomavirus in cervical intraepithelial neoplasia in a high-risk population[J].J Med Virol,2011,83(5):833-837. [2] 曹泽毅. 中华妇产科学(临床版)[M].北京:人民卫生出版社,2010:583-603. [3] IBá E Z R,AUTONELL J,SARDà M,et al. Protecting the underscreened women in developed countries:the value of HPV test[J].BMC Cancer,2014,14(1):574. [4] NADARZYNSKIT T,WALLER J,ROBB K A,et al.Perceived risk of cervical cancer among pre-screening age women(18-24 years):the impact of information about cervical cancer risk factors and the causal role of HPV[J].Sex Transm Infect,2012,19(4):652-675. [5] 钟继兴. 高危型HPV-DNA检测在宫颈癌筛查中的应用[J]. 中国医药科学,2015,5(15):144-146. [6] 李春龙,廖洪,杨瑛,等. HPV 分型及其高危亚型与宫颈病变的相关性分析[J]. 检验医学与临床,2015,12(8):1109-1111. [7] 郭晓霞,田玉旺,张立英,等. 41 751例女性宫颈细胞中HPV基因分型的回顾性分析[J]. 临床与病理杂志,2016,36(2):113-127. [8] WU E Q,LIU B,CUI J F,et al. Prevalence of type-specific human papilloma virus and pap results in Chinese women:a multi—center,population-based cross-sectional study. Cancer Causes Control,2013,24(4):795-803. [9] 岑尧,张翠英,张雅丽,等. 中国女性人乳头瘤病毒感染状况及高危型别分布的Meta 分析[J].癌症进展,2013,11(1):75-81. [10]黄紫艳,陈颖. 4 498名体检妇女高危型人乳头瘤病毒感染状况调查[J]. 预防医学,2014,26(6):613-614. [11]朱姗姗,袁何莲芝.199例妇科门诊就诊者HPV多重感染检测结果分析[J].医学信息,2015,28(5):290-291. [12]BALANDA M,QUIERO A,VERGARA N,et al. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile,2014-2015[J]. Med Microbiol Immunol,2016,205 (6):585-594.